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expanded polyglutamine tract found in the respective proteins. Although the structure of this tract in the large mature aggregates
is increasingly well described, its structure in the small early aggregates remains largely unknown. As experimental evidence
suggests that the most toxic species along the aggregation pathway are the small early ones, developing strategies to alleviate
disease pathology calls for understanding the structure of polyglutamine peptides in the early stages of aggregation. Here, we
present a criterion, grounded in available experimental data, that allows for using kinetic stability of dimers to assess whether a
given polyglutamine conformer can be on the aggregation path. We then demonstrate that this criterion can be assessed using
present-day molecular dynamics simulations. We find that although the a-helical conformer of polyglutamine is very stable,
dimers of a-helices lack the kinetic stability necessary to support further oligomerization. Dimers of steric zipper, b-nanotube,
and b-pseudohelix conformers are also too short-lived to initiate aggregation. The b-hairpin-containing conformers, instead,
invariably form very stable dimers when their side chains are interdigitated. Combining these findings with the implications of
recent solid-state NMR data on mature fibrils, we propose a possible pathway for the initial stages of polyglutamine aggregation,
in which b-hairpin-containing conformers act as templates for fibril formation.INTRODUCTIONProtein misfolding and aggregation is connected to many
devastating neurodegenerative diseases. One particularly
interesting subset of these pathologies comprises the poly-
glutamine (polyQ) disorders, including Huntington’s dis-
ease and several ataxias (1). In these dominantly inherited
diseases, the aggregating protein contains a polyQ sequence
that has expanded beyond a certain threshold (typically be-
tween 30 and 40 consecutive glutamines), conferring patho-
genicity and triggering the aggregation of the protein in
question (1,2). The sequences flanking the polyQ stretch
vary among the proteins, leading to differences in the exact
threshold length, age of disease onset, and the course of neu-
rodegeneration (3,4). However, as the expanded polyQ
stretch is the only common feature among the disease-
causing polyQ proteins, understanding its structure andSubmitted October 15, 2013, and accepted for publication February 25,
2014.
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0006-3495/14/04/1721/8 $2.00properties seems to be key to understanding their shared
pathological behavior.
The mature fibrillar aggregates of different polyQ proteins
appear to have b-rich secondary structurewith a core that has
been shown to be dominated by the polyQ stretch (5–7).
Using model peptides focused on the polyQ stretch, the
principal details of the core structure have emerged: most
likely the b-strands run perpendicular to the fibril axis, anti-
parallel b-sheets form along the axis, and the b-sheets stack
such that their side chains interdigitate (8–10). Mounting
evidence suggests, however, that these mature aggregates
are not toxic enough to be the main culprits of neuronal death
(11–19). On the other hand, some small soluble species
occurring in the initial stages of aggregation are probably
highly toxic (20–27), but here the structural details are
largely missing. Revealing the polyQ conformers that occur
during the initial stages of aggregation would, therefore, be
beneficial for developing strategies that aim to alleviate dis-
ease pathology by targeting the toxic species.
Until now, it has not been experimentally possible to
obtain high-resolution structural information on the aggrega-
tion-initiating conformation of polyQ peptides. A number of
widely different structural models have been proposed.
These include thewater-filled b-nanotube (based on low-res-
olution x-ray diffraction on mature fibrils (28)); the dry-core
b-pseudohelix (molecular simulations (29,30)); the b-sheet
(mutational analysis (31) and solid-state NMR on fibrilshttp://dx.doi.org/10.1016/j.bpj.2014.02.027
FIGURE 1 Initiation of polyQ aggregation according to the nucleated
growth polymerization model suggested by Wetzel et al. (36,37,62). The
model considers that the nonaggregating monomer ensemble M is in
preequilibrium with the free-energetically most unfavorable state along
the aggregation pathway (state 1), in which monomers are found in a
conformation capable of initiating aggregation (36). For pathological-
length polyQ, the population ratio between the states M and 1 is estimated
to be of the order of 1,000,000,000:1 (63). Notably, due to asymmetric exit
rates (k1> kþ[M], indicated by the length and thickness of arrows), a pep-
tide in state 1 would still be much more likely to go to state M than to state 2
1722 Miettinen et al.(32)); the b-sheetstack (aggregation kinetics (33)); the steric
zipper (first speculated based on a model for another peptide
(34), recently supported by solid-state NMR on fibrils (10));
and the a-helix (bioinformatics analysis of interaction part-
ners of polyQ proteins, circular dichroism, and chemical
cross-linking (35)). However, the different models have
never been systematically compared with a view to feasi-
bility, possibly due to the lack of criteria for the assessment.
Here, we present a criterion for assessing the feasibility of
different structural models of polyQ being found on the ag-
gregation path. The criterion is deduced from a mechanistic
model regularly used to analyze polyQ aggregation kinetics,
and it is based on experimental data.We then use this criterion
to assess the likelihood of different aggregation pathways via
molecular docking calculations and atomistic molecular dy-
namics (MD) simulations. We find that most of the models
proposed in the literature cannot form the long-lived dimers
required in the early stages of aggregation. We also show
that among the different models tested, the most stable dimer
conformers always contain b-hairpins with interdigitated
side chains, indicating that the formation of this motif could
be crucial in the initial stages of polyQ aggregation.(37). From state nR 2, the state nþ 1 is more likely than state n – 1. As the
monomer concentration [M] is initially effectively constant, we depict all
the reactions as first-order, with the (second-order) growth reaction taking
place with a pseudo-first-order reaction rate kþ[M].
METHODS
Nucleated growth polymerization model
As a starting point for our analysis, we used the model sketched in Fig. 1.
The model was initially proposed based on in vitro aggregation kinetics of
polyQ peptides (36), and it has since been regularly applied in this context
(for a recent review see Wetzel (37)).
The model considers only homogeneous (primary) nucleation, and it ex-
cludes any secondary pathways, on which aggregates would spawn new
aggregates via processes such as fibril fragmentation (38) or surface-cata-
lyzed nucleation (39). This choice agrees with the experimental finding
(36) that the early-time rise in spontaneous aggregation kinetics profiles
does not show the exponential signature of a secondary nucleation mecha-
nism, but is polynomial (~t2), suggesting that primary nucleation is domi-
nant (40). The finding that seeding turns the sigmoidal profile concave
(41) also signals primary nucleation (40).
In the nonaggregating monomer ensembleM (Fig. 1) the model considers,
based on circular dichroism (42) and fluorescence correlation spectroscopy
(43), polyQ to be intrinsically disordered and to resemble a polymer collapsed
in poor solvent. Furthermore, as the mild concentration dependence of the
early-time kinetics (of pathological length polyQ, QN>25 (33)) translates
into a nucleus size of 1 in a nucleated polymerization theory analysis, the
model considers that the ensembleM is in preequilibriumwith the free-ener-
getically most unfavorable state along the aggregation pathway, state 1, in
which monomers have a particular folded form capable of triggering aggre-
gation (36). Formation of a dimer, state 2, is the first step down the free energy
landscape; from there on, an on-pathway state n has a higher likelihood of
elongating (into state nþ 1) than of dissociating (into state n 1). Aggregate
growth by monomer addition is suggested by the finding that the early poly-
merization rate is directly proportional to both monomer and aggregate con-
centrations (40,44,45).Monomeric conformers
We used PyMol (The PyMOL Molecular Graphics System, Version
1.2r3pre, Schro¨dinger, Portland, OR), VMD (46), and published structuresBiophysical Journal 106(8) 1721–1728to generate six polyglutamine conformers described in the literature: the
steric zipper (10,34), the b-nanotube (28), the b-pseudohelix (29,30), the
b-sheet (31,32), the b-sheetstack (33), and the a-helix (35). All peptides
consisted of 40 glutamine residues (Q40), with NH2/COOH termini. Their
stability as monomers has been studied previously (47).Docking
Docking calculations allow the generation of dimer structures and their
ranking according to an estimate of their binding affinity. For each of the
six Q40 conformers, we docked two identical copies of the peptide on
each other using Autodock 4.2 with its default force field parameters
(48). A Lamarckian genetic algorithm was used for searching molecular
conformations and a grid-based approach was used for energy calculations.
The size of the grid was fixed at 0.05 nm. Each docking set comprised 140
copies, and the number of searches in each copy was 25 million. For each
set, the 140 docked conformations were clustered based on their mutual
root mean-square deviation (RMSD), each group thus representing a bind-
ing mode.
First, both monomers were treated as rigid bodies. To further optimize
the docked conformations, rigid docking was followed by semiflexible
docking. Docked structures from rigid docking were examined, and the
side chains at the monomer-monomer interface were made flexible, i.e.,
the Ca-Cb bonds of side chains were allowed to rotate. If the number
of side chains at the interface exceeded 10, they were divided into
two groups, one rigid and the other flexible, and two separate sets of dock-
ing calculations were performed. Using semiflexible docking, structural
particularities of the monomer constructs appeared not to prevent
representative dimerization of the conformers, but highly compatible
(especially for steric zippers and b-sheets), as well as intuitive, dimer
structures emerged.
Note that as the entropy loss cannot be estimated, the docking scores do
not represent free energies of binding. However, high scores indicate high
dimerization propensity, and allow the selection of probable dimer
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simulations.Molecular dynamics
To assess the kinetic stability of nine high-scoring dimers obtained via
docking, we performed extensive MD simulations.
Two identical sets of atomistic simulations were performed using
GROMACS (49), version 4.5.3, one set with the united-atom GROMOS
43a1 (50) and one set with the all-atom CHARMM27 (51,52) force field.
Before starting the simulations, the structures obtained via the docking
were relaxed through two energy minimizations (using the steepest-descent
algorithm) with the respective force fields, first without and then with con-
straints. Water was then added and, with the dimer position-restrained, was
relaxed via short MD simulations. In CHARMM27, this was done with
5000 steps of 0.2 fs followed by 50,000 steps of 2 fs, in GROMOS 43a1
with 25,000 steps of 4 fs. Finally, 10 identical copies of each of the 18 sys-
tems were given new uncorrelated particle velocities from a Maxwell-
Boltzmann distribution at 310 K.
In the GROMOS 43a1 simulations, we used the simple point charge
water model (53), heavy hydrogens (54), reaction field electrostatics
(erf¼ 54), and a 4 fs time step. The van der Waals and Coulomb interactions
were cut off at 1.4 nm, and the neighbor lists (r ¼ 1.4 nm) were updated
every step. In the CHARMM27 simulations, the TIP4P water model (55),
particle-mesh Ewald (56,57) electrostatics and a 2 fs time step were used.
For particle-mesh Ewald, we used fourth-order interpolation, a 1.3 nm
real-space cutoff, a relative error of 105 in the direct and the reciprocal
space, and size-optimized fast Fourier transform parameters (grid spacing
of roughly 0.12 nm). The neighbor lists (r ¼ 1.3 nm) were updated every
10 steps, with van der Waals interactions switched off between 1.0
and 1.2 nm.
All 180 simulations had periodic dodecahedron boundary conditions
(initial distance from the dimer atoms to the face of the unit cellR1.2 nm).
Pressure was kept at 1 bar using an isotropically coupled (t ¼ 1.0 ps)
Parrinello-Rahman barostat (58). Temperature was maintained at 310 K
using the velocity rescale thermostat (59), separately coupled to the peptides
and water (t ¼ 0.1 ps in GROMOS 43a1 and 1.0 ps in CHARMM27).
Covalent bonds were constrained to their equilibrium lengths by (fourth-
order single-iteration) parallel linear constraint solver (P-LINCS) (60) in
the peptides and by SETTLE (61) in water. All 180 simulations were carried
out for 100 ns, for a total simulation time of 18 ms.RESULTS
Lifetime criterion for on-pathway dimers
The mechanistic model that we considered is suggested by
kinetic experiments on polyQ peptides (36). In the model
(see Fig. 1 and Methods), polyQ aggregation is nucleated
by an alternatively folded monomer (state 1 in Fig. 1), and
the formation of an on-pathway dimer (state 2) is the first
step downhill in the free energy landscape (36,37,62).
Notably, the on-pathway dimer has a higher likelihood of
elongating than of disintegrating (37), which gives a means
to assess whether a given dimer structure can be on the
aggregation path: The disintegration time of the on-pathway
dimer will exceed the time required for its elongation into
the on-pathway trimer (state 3).
In fact, for the diffusion along the reaction coordinate to
drive the system toward the fibrillar state, for all on-pathway
states nR2, the probability of entering the state n þ 1 mustexceed 50%. That is, going from the state n to state n þ 1
must be more likely than exiting the state n through any
disintegrative route. In terms of rate constants, this condi-
tion reads as kþ[M] > k þ kn. Here, kþ[M] and k are
as shown in Fig. 1; kn is the exit rate to any disintegrated
state other than n 1, which is considered to be vanishingly
small for on-pathway states, and is thus not drawn in Fig. 1.
Thus, a necessary condition for a given dimer structure to
be on the aggregation pathway is that its characteristic disin-
tegration time tdis ¼ 1/(k þ k2), in other words, the time
over which the dimer structure stays unchanged, exceeds the
characteristic time tfwd ¼ 1/kþ[M] needed for the elonga-
tion step to occur. Hence, for aggregation to proceed, the
dimer must fulfill the following stability condition:
tdis>tfwd ¼ 1
kþ½M ¼
1

2 104 s1 M1 50 106M
¼ 1 s:
(1)
Here, we used the conservative estimates kþ ¼ 2  104
s1 M1 and [M] ¼ 50 mM (the elongation constant kþ
has been measured to be 1.14  104 s1 M1 for
K2Q47K2 (63), and typical initial concentrations in experi-
ments are 5–200 mM; see, for example, studies by Wetzel
and colleagues (33,36,63)).
Hence, if the average lifetime of a dimer is not at least 1 s,
the dimer in question cannot be on the aggregation pathway.
In particular, for a given dimer structure to be on pathway, it
must show extreme kinetic stability on the timescale of the
hundreds of nanoseconds that is typical for MD simulations.
For the on-pathway dimer, the likelihood of disintegration
during 100 ns is 1  exp(100  109) z 107, that is,
1 in 10 million dimers is expected to disintegrate during
100 ns. The kinetic stability of peptide dimers is thus a use-
ful criterion for assessing candidate structures for the initial
stages of polyQ aggregation.
A defining feature of the lifetime criterion is that it is,
per construction, a tool of exclusion, not inclusion. It can
eliminate unfeasible structures but never fully prove that
a given structure is on pathway. This logic holds indepen-
dent of the simulation length; even stability beyond the
time limit of Eq. 1 does not provide an exact proof that a
structure is on-pathway—only that it could be. With con-
fidence, however, all structures failing to reach this time
limit can be removed from the list of possible on-pathway
candidates.Construction of polyQ dimers with peptide-
peptide docking
We generated dimers comprising two Q40 peptides using
semirigid peptide-peptide docking calculations on six dif-
ferent conformers: b-sheet, b-sheetstack, steric zipper,Biophysical Journal 106(8) 1721–1728
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docking approach, one makes the implicit assumption that
no major monomer restructuring occurs upon dimerization;
here, this assumption appears plausible, as the highest free
energy state is known to be a structured monomer (Fig. 1).
The initial monomer structures for the conformers were
the same as in our previous study (47). The docking scores
acquired from the calculations provided qualitative informa-
tion on the stability of dimers (under the assumption of
static conformers) and allowed for a rough comparison of
their elongation potentials.
The highest docking score (49, given in kcal/mol by
Autodock (48)) occurred for two exactly aligned steric
zipper peptides (Fig. 2). The high score reflected the
large number of interpeptide hydrogen bonds, indicating
that this conformer possesses a high elongation potential
along this mode of binding. A high score (30) was also
obtained when one of the monomers was rotated 180 in
the plane of its backbone. For this orientation, how-
ever, the semirigid docking did not result in a perfect
alignment of the b-strands, and no b-sheets were formed
(Fig. 2).
The second highest score (35) was obtained for a b-sheet
dimer that had the b-sheets stacked on top of one another,
with their side chains interdigitated (Fig. 2). No interpeptide
hydrogen bonding occurred, and the peptide-peptide inter-
actions were mostly dispersion interactions, as the tight-FIGURE 2 The highest-scoring polyQ dimer structures obtained with
peptide-peptide docking are shown as snapshots. One monomer is colored
red, the other blue; three N-terminal residues are represented with a lighter
shade of the same colors. The numbers indicate the docking scores (given
by Autodock in kcal/mol) of the modes of binding. The color coding of
the frames corresponds to that of the lines in Fig. 3. To see this figure in
color, go online.
Biophysical Journal 106(8) 1721–1728fitting interdigitation provided many close contacts between
the side chains.
The high-scoring b-sheet dimer was similar to the two
high-scoring configurations found for the b-sheetstack
dimer (23 and 27; Fig. 2). As the side chains were already
interdigitated in the b-sheetstack monomer, the dimeriza-
tion took place by establishing backbone-backbone and
side-chain-side-chain hydrogen bonds between the two
polyQ peptides.
The tubelike conformers (b-nanotube and b-pseudohelix)
were barely distinguishable in their scores (21 and 19),
reflecting the high similarity in their modes of binding
(along the tube axis; see Fig. 2). Interestingly, the polyQ
in a-helical conformation showed the lowest docking scores
(13 for the parallel and 10 for the antiparallel orientation),
indicating a low elongation potential.Assessment of dimer kinetic stability with MD
simulations
The dimers obtained for each conformer via docking gave
good initial configurations that were used for studying the
kinetic stability of dimers by atomistic MD simulations.
For each of the nine high-scoring dimeric structures
(Fig. 2), 10 þ 10 independent MD simulations (180 simula-
tions in total) of 100 ns were performed using two different
force fields, CHARMM27 (51,52) and GROMOS 43a1 (50),
with an explicit solvent. We emphasize that because
different MD force fields can differ in their ability to
describe some features of peptides (64–66), we repeated
all our MD simulations with two different atomistic force
fields. This gives us a good control over possible systematic
errors and allows verification of the significance of our
observations.
The kinetic stability of the conformers was estimated by
monitoring their lifetimes, which were obtained by visual in-
spection of the trajectories and analysis of theRMSDof dimer
backbone atom distances (signaling conformational changes
of the dimer), and the peptide-peptide center-of-mass dis-
tance (signaling separation of the monomers). Details of the
analysis are available in the Supporting Material.
Comparison of the kinetic stabilities revealed that the
b-hairpin-containing dimers (b-sheet and b-sheetstack di-
mers) displayed unwavering stability, maintaining their
secondary structure (Figs. S1 and S3 in the Supporting
Material) and a short intermolecular distance (Fig. S2) in
all 60 replicas throughout the 100 ns simulation (Fig. 3).
The a-helix dimers also showed rather high stability, but
disintegration events occurred in 3 of the 40 replicas: twice
via monomer separation and once through a structural
collapse of the dimer (Fig. S4). Note that the latter was
the only replica in which either of the a-helix monomers
lost its conformation.
Dimers of the other three conformers (b-nanotube,b-pseu-
dohelix, and steric zipper) showed low stability, with all
FIGURE 3 The percentage of intact dimers (whose monomers retain
their initial conformation and remain associated) as a function of MD simu-
lation time. All replicas are grouped under the conformer of the monomer,
irrespective of the relative orientation of the peptides and the force field
used. The color-coding is as in Fig. 2. To see this figure in color, go online.
Stable PolyQ Dimers Contain b-Hairpins 1725b-nanotube replicas and all but one steric zipper replica dis-
integrating before 100 ns (Fig. 3). The b-nanotube was the
only conformer in addition to the a-helix that experienced
a separation of monomers (Fig. S5).DISCUSSION
In this study, we pointed out that according to a mechanistic
model regularly used to analyze polyQ aggregation kinetics
(Fig. 1), the lifetime of an on-pathway polyQ dimer must
exceed by more than six orders of magnitude the typical
(100 ns) timescale of present-day MD simulations. There-
fore, should an on-pathway dimer be simulated via MD, it
should demonstrate extreme kinetic stability. We then
created a set of nine polyQ dimers (of six different con-
formers; see Fig. 2) and performed extensive (180 
100 ns) MD simulations on them. We found that the a-heli-
cal, b-nanotube, b-pseudohelix, and steric zipper dimers
were not stable enough to be on the polyQ aggregation
pathway. Instead, the extreme stability of dimers comprising
b-hairpins stacked such that their side chains interdigitate
(the b-sheet and b-sheetstack dimers) indicated that the
on-pathway dimers could include this motive.Characteristic lifetime
Based on the initial growth rate of on-pathway states,
kþ[M], we deduced that the characteristic lifetime of an
on-pathway dimer must exceed 1 s (Eq. 1). This estimate
is still rather conservative, as can be gauged from the rate
of the dissociation reaction, k, at the long-time limit.
When fibril formation reaches equilibrium, it holds that
k ¼ kþ[M]c. Here, [M]c is the characteristic final monomer
concentration; it is equivalent to the critical initial monomer
concentration, below which spontaneous fibril formation
does not occur. The value of [M]c has been measured exper-imentally and is known to decrease as polyQ length in-
creases: [M]c z 30 mM for K2Q15K2 (41), z3 mM for
K2Q23K2 (33), %1 mM for K2Q28K2 (67), and is still less
for longer polyQ sequences (37,41). Using the estimates
[M]c ¼ 1 mM and kþ ¼ 1.14  104 s1 M1 (still conserva-
tive for Q40) gives k ¼ 1.14 102 s1 and a characteristic
lifetime for on-pathway states of 1/kz 90 s. Should a spe-
cies have the ability to trigger neuronal death (68,69), this
could be enough time to execute the toxic mission.Kinetic stabilities of dimers
For the on-pathway dimer, no disintegration events should
occur during the 100 ns MD simulations we performed
here. Of the structures studied, only the b-sheet and b-sheet-
stack dimers achieved this (Fig. 3).
Dimers of Q40 were built by docking monomeric struc-
tures proposed in the literature. We had previously explored
their kinetic stabilities as monomers and shown that both
a-helical and b-hairpin-containing monomers have average
lifetimes exceeding 100 ns (47). With the exception of the
a-helix, all the conformers gained kinetic stability upon
dimerization.
The a-helical dimers did not demonstrate (Fig. 3) the
extreme kinetic stability required for the on-pathway dimer
(Eq. 1). In fact, as predicted by the low docking scores
(Fig. 2), the a-helical monomers did not bind to one another
very strongly, but in 5% of the MD simulations the a-helix
dimers were observed breaking into monomers. As expected
based on their robustness as monomers (47), the monomers
retained their a-helical conformations in these events. Thus,
although the polyQ stretch may populate the a-helical
conformation as a monomer (35), the elongation into fibrils
would only be feasible after a conformational conversion
(70). We conclude that the a-helical assemblies are most
likely off pathway with regard to polyQ aggregation.
The low kinetic stabilities observed here for the b-nano-
tube and the b-pseudohelix are consistent with other atom-
istic MD studies showing that (based on backbone RMSDs)
dimers of tube-like conformers have short (10–50 ns) life-
times (71,72).
The excellent compatibility of the steric zippers (signaled
by their high docking scores in Fig. 2) led to a considerable
stabilization upon dimerization: The average lifetime
increased by two orders of magnitude from the subnanosec-
ond times reported for monomers (47). Interestingly, how-
ever, this stabilization was still not enough to make the
dimers last beyond 100 ns (Fig. 3). In contrast, the
b-hairpin-containing dimers (i.e., the b-sheet and b-sheet-
stack) showed very high kinetic stability: none of the
b-hairpin-containing dimers broke during the entire simula-
tion time (60  0.1 ms). The stabilizing effect of b-hairpins
has been demonstrated previously, as a dimer created by
joining two Q15 hairpins in the same plane, forming a
four-strand b-sheet, was not stable over 10 ns (73), but aBiophysical Journal 106(8) 1721–1728
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time exceeding 100 ns (47). Our simulations are consistent
with these results and with the high stabilities reported for
large collections of extended b-strands (Q6 and Q15) orga-
nized into interdigitated b-sheets (74). Taken together, all
these findings indicate that the b-hairpin motif alone is not
sufficient to obtain an extremely stable structure, but that
side chain interdigitation, characteristic of the steric zipper
conformer, is also required. It appears that three to four
strands in the b-sheet direction and two strands in the ste-
ric-zipper direction is enough for creating a highly stable
system. The high stability is particularly interesting in light
of reports indicating that the very toxic soluble species
contain b-hairpins (23,75,76).Possible pathway
It is noteworthy that the three conformers we found to have
the highest docking scores (steric zipper, b-sheet, and
b-sheetstack) differ only in their turn regions (Fig. 2). The
turns are sharp hairpins in the b-sheet and rather gentle
arches in the steric zipper (77). The b-sheetstack includes
both turn types and thus demonstrates the compatibility of
the b-sheet and steric-zipper conformers. Notably, all three
could, in principle, fit the tight packing of b-strands found in
the final fibrils.
The steric-zipper-based fibril was recently supported by
Schneider et al. (10). They report their solid-state NMR re-
sults to be most compatible with peptides in a steric-zipper-
like conformation, and not with a conformation containing
b-hairpins. The high docking scores we obtained for the
steric zipper (Fig. 2) are consistent with the results of
Schneider et al. However, as is evident from the lack of
kinetic stability of the steric-zipper dimer (Fig. 3), a docking
event of this kind is feasible only if a robust, steric-zipper-
compatible fibril already exists.
Support for the b-hairpin-containing fibrils, then, came
from Kar et al. (32). The authors used solid-state NMR to
show that certain b-hairpin-enhancing mutations in polyQ
peptides do not change the resulting fibril structure. The for-
mation rates of fibrils, however, increase greatly. They thus
argue that b-hairpin-containing structures are the ones most
likely to be found in the nucleus and in the final fibril. Our
main finding that only the b-hairpin-containing dimers are
long-lived enough to be on pathway (Fig. 3) is consistent
with the results of Kar et al. However, fibril elongation
can evidently not occur via b-sheet stacking (which was
the arrangement found by the docking algorithm for the
b-sheet dimer; see Fig. 2), as the fibril axis should be aligned
with (and not perpendicular to) the plane of the b-sheets
forming it (9,78).
In short, it seems that in the nucleation event, b-hairpin-
containing conformers are required (32), whereas steric zip-
pers better fit the final fibril (10). Based on our findings, we
suggest that a possible explanation to this apparent contra-Biophysical Journal 106(8) 1721–1728diction lies in the inherent compatibility of the two con-
formers. As we demonstrated, the steric zipper dimers are
too unstable to be on the aggregation path. In the initial
stages of aggregation, the b-hairpin motif thus appears
crucial. We also demonstrated that for unwavering stability
the side chains of the b-hairpins should be interdigitated.
This, notably, creates a surface that is compatible with the
steric zipper conformer. We therefore suggest that in the
initial stages, b-hairpin-containing peptides come together,
creating a robust surface, on which further peptides then
deposit themselves in the steric-zipper conformation.
This pathway agrees with the findings that the final
fibrils contain predominantly steric zippers (10), and that
enhancing the ability of b-hairpin formation will enhance
the rate of fibril formation (32). Furthermore, it explains
the finding of Kar et al. that although the nucleation of
fibril formation is greatly facilitated by the b-hairpin-
enhancing insertion, the elongation phase is actually
somewhat retarded by it (32). Evidently, a preference for
b-hairpins would speed up the initial steps on our suggested
path, but would slow down the later steps, in which archlike
turns, characteristic of the steric-zipper conformer, need
to form.
The possible implications of this pathway for medicine
would be related to the relatively benign effects of the
mature aggregates (11–19) versus the high toxicity of early
soluble species (20–27). Therapeutic strategies could be
designed to encourage steric-zipper-like conformers (and
thus aggregate maturation) while discouraging b-hairpin
formation (and thus aggregate emergence).SUPPORTING MATERIAL
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